Zhejiang Lanyu Digital Technology
301585
BBK Test Systems
301598
MEIZHIGAO
834765
Youkeshu Technology
300209
Hangzhou Raycloud Technology Co.,Ltd
688365
CN Stock MarketDetailed Quotes
002390 Guizhou Xinbang Pharmaceutical
- 4.15
- -0.03-0.72%
Not Open Dec 20 15:00 CST
8.07BMarket Cap37.05P/E (TTM)
4.23High4.14Low221.31KlotVolume4.19Open4.18Pre Close92.43MTurnover1.20%Turnover Ratio28.04P/E (Static)1.94BShares4.6852wk High1.19P/B7.68BFloat Cap2.8352wk Low4.60Limit Up1.85BShs Float26.35Historical High3.76Limit Down2.15%Amplitude1.47Historical Low0.09Dividend TTM4.18Avg Price111.61KlotAsk2.17%Div YieldTTM100Lot Size93.45KlotBid
Guizhou Xinbang Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -5.35%4.57B | -6.45%3.05B | -1.41%1.58B | 1.75%6.46B | 2.92%4.82B | 3.59%3.26B | 1.70%1.61B | -1.88%6.35B | -0.78%4.69B | 1.46%3.14B |
| Operating revenue | -5.35%4.57B | -6.45%3.05B | -1.41%1.58B | 1.75%6.46B | 2.92%4.82B | 3.59%3.26B | 1.70%1.61B | -1.88%6.35B | -0.78%4.69B | 1.46%3.14B |
| Other operating revenue | ---- | -7.84%15.73M | ---- | 29.04%24.98M | ---- | -0.01%17.06M | ---- | -37.07%19.36M | ---- | -2.59%17.07M |
| Total operating cost | -4.34%4.28B | -5.73%2.86B | -2.33%1.5B | 0.24%6.03B | 1.39%4.47B | 2.12%3.03B | 3.00%1.54B | 0.20%6.02B | -0.30%4.41B | 1.71%2.97B |
| Operating cost | -3.53%3.72B | -4.59%2.5B | -0.53%1.31B | 1.93%5.23B | 3.25%3.86B | 4.37%2.62B | 3.31%1.31B | 0.27%5.13B | 0.20%3.74B | 2.10%2.51B |
| Operating tax surcharges | -8.84%19M | -10.76%11.89M | 0.79%6.93M | -2.69%27.43M | 0.37%20.84M | 3.73%13.32M | -0.48%6.88M | -1.80%28.19M | -0.49%20.76M | 4.70%12.84M |
| Operating expense | -10.04%229.26M | -15.55%146.66M | -14.94%72.87M | -12.70%343.41M | -13.80%254.85M | -10.01%173.66M | -6.45%85.66M | 9.21%393.37M | 3.10%295.66M | 5.05%192.98M |
| Administration expense | -6.70%287.37M | -8.81%188.43M | -8.57%106.72M | -6.26%394.42M | -1.51%308.01M | -8.16%206.64M | 9.89%116.73M | 3.53%420.77M | 4.16%312.75M | 13.59%224.99M |
| Financial expense | -45.95%13.2M | -44.04%9M | -56.33%4.88M | -28.80%27.75M | -40.07%24.41M | -40.65%16.08M | -19.04%11.18M | -55.28%38.98M | -50.71%40.74M | -58.33%27.09M |
| -Interest expense (Financial expense) | -42.63%18.57M | -41.61%12.59M | -51.86%6.66M | -23.34%39.7M | -31.80%32.37M | -29.77%21.57M | -10.06%13.84M | -48.31%51.79M | -49.74%47.45M | -58.57%30.7M |
| -Interest Income (Financial expense) | 30.09%-6M | 32.30%-4.04M | 29.41%-2.02M | 5.98%-12.73M | -18.01%-8.59M | -39.92%-5.96M | -47.97%-2.86M | 3.30%-13.54M | 41.48%-7.28M | 55.50%-4.26M |
| Research and development | 86.83%3.82M | 29.37%2.16M | 25.24%865.89K | 287.11%4.67M | 354.16%2.05M | 521.04%1.67M | 398.74%691.39K | -37.70%1.21M | -39.56%450.76K | -70.63%268.29K |
| Credit Impairment Loss | -54.30%-25.82M | -29.65%-21.71M | -1,431.52%-3.34M | 15.18%-53.13M | -74.44%-16.73M | -102.25%-16.74M | -10.27%251.09K | -107.61%-62.63M | 13.00%-9.59M | 0.62%-8.28M |
| Asset Impairment Loss | ---- | ---- | ---- | ---7.52M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other net revenue | -68.32%-21.25M | -32.19%-19.52M | -280.33%-2.38M | -152.91%-45.85M | -138.54%-12.62M | -239.95%-14.77M | -2.37%1.32M | -9.50%-18.13M | 2,705.15%32.75M | -345.88%-4.34M |
| Invest income | 264.84%1.3M | ---- | ---- | -74.89%9.4M | -102.11%-788.94K | -17,250.95%-2.03M | --4.57K | 854.70%37.43M | 1,043.54%37.43M | -99.62%11.86K |
| Asset deal income | 54.69%-25.31K | 77.54%-9.67K | 69.00%-11.75K | 493.81%17.8K | 25.54%-55.86K | 49.25%-43.05K | 71.28%-37.88K | 98.93%-4.52K | 5.54%-75.03K | -293.01%-84.82K |
| Other revenue | -33.48%3.3M | -45.77%2.2M | -11.13%977.96K | -23.98%5.38M | -0.81%4.95M | 1.15%4.05M | -8.47%1.1M | -29.99%7.08M | -44.51%5M | -42.51%4.01M |
| Operating profit | -21.36%267.24M | -19.64%167.76M | 13.32%80.6M | 21.72%385.03M | 9.77%339.85M | 23.40%208.76M | -20.11%71.12M | -29.94%316.32M | 2.71%309.61M | -5.98%169.18M |
| Add:Non operating Income | -68.91%735.02K | -59.19%595.47K | -76.92%281.04K | 125.26%25.01M | -47.38%2.36M | -67.45%1.46M | 447.32%1.22M | 20.97%11.1M | -34.12%4.49M | -27.06%4.48M |
| Less:Non operating expense | -43.07%3.71M | 61.92%2.26M | 758.24%1.29M | -0.07%14.02M | 50.73%6.51M | 394.16%1.4M | -48.22%150.05K | -64.53%14.03M | -86.32%4.32M | -95.03%283.06K |
| Total profit | -21.28%264.27M | -20.46%166.09M | 10.25%79.59M | 26.37%396.02M | 8.37%335.7M | 20.44%208.82M | -18.85%72.19M | -25.58%313.39M | 11.97%309.78M | -3.89%173.38M |
| Less:Income tax cost | -2.23%31.53M | -14.96%14.65M | -17.24%7.9M | -6.40%42.25M | -2.43%32.26M | -0.82%17.22M | 1.23%9.54M | -4.31%45.14M | -3.01%33.06M | -21.13%17.37M |
| Net profit | -23.30%232.74M | -20.96%151.44M | 14.44%71.69M | 31.88%353.77M | 9.66%303.45M | 22.81%191.6M | -21.23%62.65M | -28.27%268.26M | 14.07%276.72M | -1.50%156.01M |
| Net profit from continuing operation | -23.30%232.74M | -20.96%151.44M | 14.44%71.69M | 31.95%353.77M | 9.66%303.45M | 22.81%191.6M | -21.23%62.65M | -28.30%268.12M | 14.07%276.72M | -1.50%156.01M |
| Net income from discontinuing operating | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --139.48K | ---- | ---- |
| Less:Minority Profit | -1.27%56.15M | 2.77%36.56M | 32.62%12.87M | 51.64%66.54M | 59.34%56.87M | 45.13%35.58M | 60.17%9.7M | -56.59%43.88M | 9.81%35.69M | 326.27%24.51M |
| Net profit of parent company owners | -28.38%176.59M | -26.37%114.88M | 11.11%58.82M | 28.02%287.23M | 2.30%246.57M | 18.65%156.02M | -27.94%52.94M | -17.77%224.37M | 14.73%241.03M | -13.84%131.5M |
| Earning per share | ||||||||||
| Basic earning per share | -27.01%0.0927 | -25.03%0.0602 | 0.00%0.03 | 25.00%0.15 | 2.42%0.127 | 18.79%0.0803 | -25.00%0.03 | -20.00%0.12 | 0.57%0.124 | -29.88%0.0676 |
| Diluted earning per share | -27.01%0.0927 | -25.03%0.0602 | 0.00%0.03 | 25.00%0.15 | 2.42%0.127 | 18.79%0.0803 | -25.00%0.03 | -20.00%0.12 | 0.57%0.124 | -29.88%0.0676 |
| Other composite income | ||||||||||
| Total composite income | -23.30%232.74M | -20.96%151.44M | 14.44%71.69M | 31.88%353.77M | 9.66%303.45M | 22.81%191.6M | -21.23%62.65M | -28.27%268.26M | 14.07%276.72M | -1.50%156.01M |
| Total composite income of parent company owners | -28.38%176.59M | -26.37%114.88M | 11.11%58.82M | 28.02%287.23M | 2.30%246.57M | 18.65%156.02M | -27.94%52.94M | -17.77%224.37M | 14.73%241.03M | -13.84%131.5M |
| Total composite income of minority owners | -1.27%56.15M | 2.77%36.56M | 32.62%12.87M | 51.64%66.54M | 59.34%56.87M | 45.13%35.58M | 60.17%9.7M | -56.59%43.88M | 9.81%35.69M | 326.27%24.51M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
